Drug Trial Radar · NCT06932562
A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant
Last checked: Nov 19, 2026Latest source record: Mar 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
1,000
Planned (sponsor's estimate)
Start
Dec 23, 2025
Primary completion
Dec 2036
Study completion Dec 2036
Sponsor
- Lead sponsor
- European Myeloma Network B.V.Research network
- Sponsor type
- Research network
- Collaborators
- Regeneron Pharmaceuticals
- First posted
- Apr 17, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is researching an experimental drug called linvoseltamab. The study is focused on participants with newly diagnosed multiple myeloma (NDMM) who are ineligible for autologous stem cell transplantation (transplant-ineligible). The main purpose of this study is to compare the effect and safety of linvoseltamab with the effect and safety of the standard treatment.
Conditions
- Multiple Myeloma
Interventions
LinvoseltamabDrug
Administered per the protocol
DaratumumabDrug
Administered per the protocol
LenalidomideDrug
Administered per the protocol
DexamethasoneDrug
Administered per the protocol
Primary outcomes
What the sponsor says the trial is designed to measure.
- Minimal Residual Disease (MRD)Time frame: up to 11 years
- MRD negative CR status by BICRTime frame: up to 11 years
- Progression Free Survival (PFS) per IMWG criteriaTime frame: up to 11 years
- PFS as determined by BICRTime frame: up to 11 years
Locations
59 sites in 18 countries. Site status is shown where the registry gives one.
Flinders Medical Centre
Adelaide, Australia · Recruiting
Box Hill Hospital
Box Hill, Australia · Recruiting
Canberra Hospital
Canberra, Australia · Recruiting
Barwon Health, University Hospital Geelong
Geelong, Australia · Recruiting
Austin Hospital
Heidelberg, Australia · Recruiting
Nepean Cancer Centre
Kingswood, Australia · Recruiting
Northern Hospital
Melbourne, Australia · Recruiting
Sunshine Coast Health
Sunshine Coast, Australia · Recruiting
Ordensklinikum Linz
Linz, Austria · Recruiting
Klinik Ottakring
Vienna, Austria · Recruiting
University Hospital Centre Zagreb - Clinic for Internal Medicine
Zagreb, Croatia · Recruiting
Fakultni Nemocnice Hradec Kralove
Hradec Králové, Czechia · Recruiting
University Hospital Olomouc
Olomouc, Czechia · Recruiting
Fakultni Nemocnice Ostrava
Ostrava, Czechia · Recruiting
Fakultni Nemocnice Plzen
Pilsen, Czechia · Recruiting
Aarhus Universitetshospital
Aarhus, Denmark · Recruiting
North Estonia Medical Centre Foundation
Tallinn, Estonia · Recruiting
Tartu University Hospital
Tartu, Estonia · Recruiting
Helsinki University Hospital Comprehensive Cancer Center
Helsinki, Finland · Recruiting
Kuopio University Hospital
Kuopio, Finland · Recruiting
Universitaetsmedizin Greifswald
Greifswald, Germany · Recruiting
Universitaetsklinikum Schleswig-Holstein -Campus Luebeck - Klinik fuer Haematologie und Onkologie
Lübeck, Germany · Recruiting
University Hospital of Würzburg
Würzburg, Germany · Recruiting
University Hospital of Alexandroupolis
Alexandroupoli, Greece · Recruiting
Alexandra General Hospital -Department of Clinical Therapeutics N.K. Univ. of Athens
Athens, Greece · Recruiting
Evaggelismos Hospital
Athens, Greece · Recruiting
Theagenion Cancer Hospital
Thessaloniki, Greece · Recruiting
Cork University Hospital
Cork, Ireland · Recruiting
Beaumont Hospital
Dublin, Ireland · Recruiting
University Hospital Limerick - Department of Haematology
Limerick, Ireland · Recruiting
AOU Ospedali Riuniti di Ancona
Ancona, Italy · Recruiting
Azienda Ospedaliera Santa Croce e Carle - Ematologia
Cuneo, Italy · Recruiting
A.O.U. Careggi
Florence, Italy · Recruiting
IRCCS Ospedale Policlinico San Martino
Genova, Italy · Recruiting
Ospedale di Legnano, ASST Ovest Milanese
Legnano, Italy · Recruiting
Meldola-Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.)
Meldola, Italy · Recruiting
ASST Grande Ospedale Metropolitano Niguarda
Milan, Italy · Recruiting
Ospedale Maggiore Policlinico, Fondazione IRCCS Ca' Granda - Oncologia
Milan, Italy · Recruiting
Azienda USL IRCCS Di Reggio Emilia
Reggio, Italy · Recruiting
Ospedale "Infermi" di Rimini
Rimini, Italy · Recruiting
Showing 40 of 59 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.